Cardiovascular disease is the leading cause of death for women worldwide, with mortality rates due to cardiogenic shock (CS) remaining exceedingly high. Sex-based disparities in the timely delivery of optimal CS treatment contribute to poor outcomes; addressing these disparities is a major priority to improve women's cardiovascular health. This consensus statement provides a comprehensive summary of the current state of treatment of CS in women across the spectrum of cardiovascular disease states and identifies important gaps in evidence. As sex-based data are limited in contemporary literature, clinicians may use this document as a resource to guide practice. Further investigations are necessary to inform best practices for the diagnosis and treatment of women with CS.
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA) / Baron, S. J.; Chou, J. C.; Shah, T.; Vest, A. R.; Abbott, J. D.; Alasnag, M.; Aurigemma, C.; Barbato, E.; Bellumkonda, L.; Bortnick, A. E.; Chieffo, A.; Geuns, R. -J. V.; Grines, C. L.; Halvorsen, S.; Hassager, C.; Kapur, N. K.; Naidu, S. S.; Ng, V. G.; Saw, J.; Lansky, A. J.. - In: JOURNAL OF THE SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY & INTERVENTIONS. - ISSN 2772-9303. - 4:6(2025). [10.1016/j.jscai.2024.102150]
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA)
Aurigemma C.;Barbato E.;Chieffo A.;Halvorsen S.;
2025
Abstract
Cardiovascular disease is the leading cause of death for women worldwide, with mortality rates due to cardiogenic shock (CS) remaining exceedingly high. Sex-based disparities in the timely delivery of optimal CS treatment contribute to poor outcomes; addressing these disparities is a major priority to improve women's cardiovascular health. This consensus statement provides a comprehensive summary of the current state of treatment of CS in women across the spectrum of cardiovascular disease states and identifies important gaps in evidence. As sex-based data are limited in contemporary literature, clinicians may use this document as a resource to guide practice. Further investigations are necessary to inform best practices for the diagnosis and treatment of women with CS.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
